Company Filing History:
Years Active: 2021
Title: Mayur Mukim: Innovator in Fused Bicyclic Compounds
Introduction
Mayur Mukim is a notable inventor based in Mumbai, India. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on fused bicyclic compounds. His research focuses on the development of compounds that serve as inhibitors of GPR91, a target of interest in various medical conditions.
Latest Patents
Mayur Mukim holds a patent for "Fused bicyclic compounds, compositions and applications thereof." This patent describes fused bicyclic compounds that are effective inhibitors of GPR91. The compounds, along with their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions, are useful in the treatment, prevention, prophylaxis, management, or adjunct treatment of all medical conditions related to the inhibition of GPR91. He has 1 patent to his name.
Career Highlights
Mayur Mukim is currently associated with Impetis Biosciences Limited, where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for conditions linked to GPR91 inhibition.
Collaborations
Some of his notable coworkers include Nadim Shaikh and Mahesh Thakkar, who contribute to the collaborative efforts at Impetis Biosciences Limited.
Conclusion
Mayur Mukim's innovative work in the field of fused bicyclic compounds showcases his commitment to advancing medical science. His contributions are expected to have a lasting impact on the treatment of various medical conditions.